Daniel R Passeri - Net Worth and Insider Trading
Daniel R Passeri Net Worth
The estimated net worth of Daniel R Passeri is at least $759,316 dollars as of 2024-04-28. Daniel R Passeri is the Director of Curis Inc and owns about 39,780 shares of Curis Inc (CRIS) stock worth over $575,617. Daniel R Passeri is also the CHIEF EXECUTIVE OFFICER of Cue Biopharma Inc and owns about 134,578 shares of Cue Biopharma Inc (CUE) stock worth over $183,699. Details can be seen in Daniel R Passeri's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel R Passeri has not made any transactions after 2023-08-14 and currently still holds the listed stock(s).
Transaction Summary of Daniel R Passeri
Daniel R Passeri Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel R Passeri owns 2 companies in total, including Cue Biopharma Inc (CUE) , and Curis Inc (CRIS) .
Click here to see the complete history of Daniel R Passeri’s form 4 insider trades.
Insider Ownership Summary of Daniel R Passeri
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CUE | Cue Biopharma Inc | 2023-08-14 | director & CEO |
| CRIS | Curis Inc | 2015-12-30 | Chief Executive Officer |
Daniel R Passeri Latest Holdings Summary
Daniel R Passeri currently owns a total of 2 stocks. Among these stocks, Daniel R Passeri owns 39,780 shares of Curis Inc (CRIS) as of December 30, 2015, with a value of $575,617 and a weighting of 75.81%. Daniel R Passeri also owns 134,578 shares of Cue Biopharma Inc (CUE) as of August 14, 2023, with a value of $183,699 and a weighting of 24.19%.
Latest Holdings of Daniel R Passeri
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRIS | Curis Inc | 2015-12-30 | 39,780 | 14.47 | 575,617 |
| CUE | Cue Biopharma Inc | 2023-08-14 | 134,578 | 1.37 | 183,699 |
Holding Weightings of Daniel R Passeri
Daniel R Passeri Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel R Passeri has made a total of 0 transactions in Curis Inc (CRIS) over the past 5 years. The most-recent trade in Curis Inc is the sale of 5,120 shares on December 30, 2015, which brought Daniel R Passeri around $76,032.
According to the SEC Form 4 filings, Daniel R Passeri has made a total of 4 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Cue Biopharma Inc is the acquisition of 3,000 shares on August 14, 2023, which cost Daniel R Passeri around $8,580.
Insider Trading History of Daniel R Passeri
- 1
Daniel R Passeri Trading Performance
GuruFocus tracks the stock performance after each of Daniel R Passeri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel R Passeri is -11.6%. GuruFocus also compares Daniel R Passeri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel R Passeri within 3 months outperforms 2 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel R Passeri's insider trading performs compared to the benchmark.
Performance of Daniel R Passeri
Average Return
51.96%
Outperforming Transactions
43%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.33 | -11.6 | -1.13 | 51.96 | 10.76 | -2.5 |
| Relative Return to S&P 500(%) | -2.36 | -11.41 | -1.78 | 49.45 | 0.71 | -13.59 |
Daniel R Passeri Ownership Network
Ownership Network List of Daniel R Passeri
Ownership Network Relation of Daniel R Passeri
Daniel R Passeri Owned Company Details
What does Cue Biopharma Inc do?
Who are the key executives at Cue Biopharma Inc?
Daniel R Passeri is the director & CEO of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include President and CSO Anish Suri , Chief Medical Officer Matteo Levisetti , and Chief Business Officer Patricia Nasshorn .
Cue Biopharma Inc (CUE) Insider Trades Summary
Over the past 18 months, Daniel R Passeri made 1 insider transaction in Cue Biopharma Inc (CUE) with a net purchase of 3,000. Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net sale of 9,325 shares made by Peter A Kiener , a net purchase of 4,000 shares made by Anish Suri ,
In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,325 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net sale of 2,325 shares.
Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cue Biopharma Inc Insider Transactions
Daniel R Passeri Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel R Passeri. You might contact Daniel R Passeri via mailing address: 40 Guest Street, Boston Ma 02135.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
